Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
deals
2
×
glaxosmithkline
2
×
investing
life sciences
national blog main
national top stories
startups
a2 biotherapeutics
aduro biotech
agency
akili interactive labs
alicia hager
allosteric
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
arca biopharma
arch venture partners
arrowhead pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
axovant gene therapies
bacteriophage
biogen
biontech
biotech ipos
boston
boulder/denver blog main
boulder/denver top stories
brace pharma
bridgebio
bristol-myers squibb
cancer
cancer immunotherapy
What
address
adds
ago
alliance
allosteric
bio
bristol
buy
calls
changing
clinic
color
crispr
days
disease
elusive
growing
hotspot
hours
kudos
leaves
medicines
molecules
myers’s
new
notifying
october
path
phone
potential
rnai
roundup
rouse
scientists
set
shorter
slumber
steer
targets
therapeutics
Language
unset
2
×
Current search:
glaxosmithkline
×
deals
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic